| Arthur Weaver, DO | |
|
5310 S 84th St, Omaha, NE 68127-3775 | |
| (402) 827-6510 | |
| Not Available |
| Full Name | Arthur Weaver |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Experience | 40 Years |
| Location | 5310 S 84th St, Omaha, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285723643 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 17638 (Nebraska) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vwb Llc | 7113349895 | 8 |
News Archive
After reviewing more than 13,000 entries, the Telly Awards® and their Silver Council announced the Shire and PharmtoMarket (P2M) produced "ADHD News Network Broadcast: 11/18/2009" had received the coveted 2010 Telly Award for video broadcasting and production.
Biogen Idec and Neurimmune Holding AG today announced that Biogen Idec has acquired a subsidiary of Neurimmune, which includes the world-wide rights to three pre-clinical immunotherapy programs. The three programs are focused on the discovery and development of novel human antibodies that address three central nervous system (CNS) targets: alpha-synuclein, tau and TDP-43.
Alnylam Biotherapeutics, a division of Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the presentation of new data at the Cell Culture Engineering XII conference held in Alberta, Canada from April 25 - 30, 2010. Alnylam Biotherapeutics was formed by Alnylam to develop RNAi technologies for application in manufacturing processes for biotherapeutic products, including recombinant proteins and monoclonal antibodies.
NPR began a series called "Is That So?": "As the debate about the health overhaul bill goes on (and on and on) you might find that sometimes what one Senator says seems to be the exact opposite of the next." In the first installment, NPR's Julie Rovner examined Sen. Christopher Dodd's statement: "On the day this bill is enacted, health insurance becomes a buyer's market, not a seller's market. And that's as American as apple pie," and found that "it may be so eventually, but definitely not on the day the bill is enacted."
› Verified 4 days ago
| Entity Name | Vwb Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154943835 PECOS PAC ID: 7113349895 Enrollment ID: O20200625002066 |
News Archive
After reviewing more than 13,000 entries, the Telly Awards® and their Silver Council announced the Shire and PharmtoMarket (P2M) produced "ADHD News Network Broadcast: 11/18/2009" had received the coveted 2010 Telly Award for video broadcasting and production.
Biogen Idec and Neurimmune Holding AG today announced that Biogen Idec has acquired a subsidiary of Neurimmune, which includes the world-wide rights to three pre-clinical immunotherapy programs. The three programs are focused on the discovery and development of novel human antibodies that address three central nervous system (CNS) targets: alpha-synuclein, tau and TDP-43.
Alnylam Biotherapeutics, a division of Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the presentation of new data at the Cell Culture Engineering XII conference held in Alberta, Canada from April 25 - 30, 2010. Alnylam Biotherapeutics was formed by Alnylam to develop RNAi technologies for application in manufacturing processes for biotherapeutic products, including recombinant proteins and monoclonal antibodies.
NPR began a series called "Is That So?": "As the debate about the health overhaul bill goes on (and on and on) you might find that sometimes what one Senator says seems to be the exact opposite of the next." In the first installment, NPR's Julie Rovner examined Sen. Christopher Dodd's statement: "On the day this bill is enacted, health insurance becomes a buyer's market, not a seller's market. And that's as American as apple pie," and found that "it may be so eventually, but definitely not on the day the bill is enacted."
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Arthur Weaver, DO 5310 S 84th St, Omaha, NE 68127-3775 Ph: (402) 827-6510 | Arthur Weaver, DO 5310 S 84th St, Omaha, NE 68127-3775 Ph: (402) 827-6510 |
News Archive
After reviewing more than 13,000 entries, the Telly Awards® and their Silver Council announced the Shire and PharmtoMarket (P2M) produced "ADHD News Network Broadcast: 11/18/2009" had received the coveted 2010 Telly Award for video broadcasting and production.
Biogen Idec and Neurimmune Holding AG today announced that Biogen Idec has acquired a subsidiary of Neurimmune, which includes the world-wide rights to three pre-clinical immunotherapy programs. The three programs are focused on the discovery and development of novel human antibodies that address three central nervous system (CNS) targets: alpha-synuclein, tau and TDP-43.
Alnylam Biotherapeutics, a division of Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the presentation of new data at the Cell Culture Engineering XII conference held in Alberta, Canada from April 25 - 30, 2010. Alnylam Biotherapeutics was formed by Alnylam to develop RNAi technologies for application in manufacturing processes for biotherapeutic products, including recombinant proteins and monoclonal antibodies.
NPR began a series called "Is That So?": "As the debate about the health overhaul bill goes on (and on and on) you might find that sometimes what one Senator says seems to be the exact opposite of the next." In the first installment, NPR's Julie Rovner examined Sen. Christopher Dodd's statement: "On the day this bill is enacted, health insurance becomes a buyer's market, not a seller's market. And that's as American as apple pie," and found that "it may be so eventually, but definitely not on the day the bill is enacted."
› Verified 4 days ago
Dr. Daniel J Gross, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 1501 Jackson St Ste 100, Omaha, NE 68102 Phone: 402-999-2329 Fax: 402-915-0095 | |
Dr. Vijay Kumar Agarwal, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 727 N 120th St, Omaha, NE 68154 Phone: 402-493-2100 Fax: 402-493-2104 | |
Mr. Joseph Kennedy Costello Iv, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 224 N. 49th St. #4a, Omaha, NE 68132 Phone: 402-659-4247 | |
Dr. Louise Winter, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 14104 S St, Omaha, NE 68137 Phone: 402-827-6710 | |
Dr. James Bane, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 11106 N 61st St, Omaha, NE 68152 Phone: 402-573-9398 | |
Andrew Walid Mezher, MD General Practice Medicare: Medicare Enrolled Practice Location: 981045 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-1018 |